A prospective, non-interventional, observational, multi-center trial to evaluate compliance and efficacy in mono and combination treatment of Candesartan cilexetil(Atancand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12.5mg(Atancand plus) in hypertension.

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].